Hubei Hongyuan Pharmaceutical Technology Co., Ltd., together with its subsidiaries, engages in the production and sale of pharmaceutical products in China and internationally. It provides active pharmaceutical ingredients, such as metronidazole, benzoyl metronidazole, dimetrizole, and acyclovir; pharmaceutical intermediates, including imidazole, glyoxylic acid, 2-methyl imidazole, 2-methyl-5-nitroimidazole, sulfate, diacetyl guanine, guanine, and diacetylacyclovir; organic chemical raw materials comprising glyoxal, and oxalic acid; and new energy materials consisting of lithium hexafluorophosphate. The company was founded in 2002 and is headquartered in Huanggang, China.
Metrics to compare | 301246 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship301246PeersSector | |
---|---|---|---|---|
P/E Ratio | 213.3x | 31.2x | −0.5x | |
PEG Ratio | −4.67 | −0.17 | 0.00 | |
Price/Book | 1.4x | 3.2x | 2.6x | |
Price / LTM Sales | 3.5x | 4.8x | 3.3x | |
Upside (Analyst Target) | - | 15.0% | 43.4% | |
Fair Value Upside | Unlock | 4.8% | 7.1% | Unlock |